课题基金 / 基金详情

Microglial Modulation of Nicotine Dependence

Microglial Modulation of Nicotine Dependence
小胶质细胞对尼古丁依赖性的调节
批准号:
9976881
负责人:
Erin Leigh Anderson
金额:
$5.4万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-05-01 至 2022-04-30
关键词:
AbstinenceAdultAffectAffective SymptomsAnimal ModelAnimalsAnti-Inflammatory AgentsAntiinflammatory EffectAnxietyApoptoticAttenuatedBehavioralBiochemicalBiological AssayBrainBrain regionCell NucleusCellsCessation of lifeCharacteristicsChronicCorpus striatum structureCytokine ReceptorsDataDiseaseDrug TargetingDrug usageEquilibriumGene ProteinsGenerationsGliosisGrowth FactorImaging TechniquesImmuneImmune responseInflammationInflammatoryIschemiaLinkMalignant NeoplasmsMarbleMeasurementMediatingMediator of activation proteinMicrogliaMinocyclineMolecularMorphologyMusMyelogenousMyeloid CellsNeurodegenerative DisordersNeurologyNicotineNicotine DependenceNicotine Use DisorderNicotine WithdrawalNucleus AccumbensPathway interactionsPharmaceutical PreparationsPharmacologyPharmacotherapyPhenotypePropertyPsychiatryReportingResearchRestRoleSignal TransductionSmokeSmokerSmokingStrokeStructureSubstance Use DisorderSubstance abuse problemSurgeonSynaptic TransmissionTLR4 geneTNF geneTetracyclinesTherapeuticTissuesTobaccoTobacco Use DisorderTobacco smoking behaviorTobacco useTraumatic CNS injuryUnited StatesVentral StriatumWithdrawalWithdrawal Symptomantimicrobialanxiety-like behaviorattenuationbehavioral phenotypingbrain cellchemokineclinically relevantcytokineexperiencefield studyfluorescence imagingimmunoregulationimprovedinhibitor/antagonistinnovationinsightmRNA Expressionmouse modelnervous system disorderneuroinflammationnicotine usenovelpreventpreventable deathprotein expressionreceptorresponsesexsmoking cessationsuccesssymptomatologytherapeutic targettoolwithdrawal-induced anxiety

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract: Notwithstanding great strides in lowering the percentage of smoking adults, close to a billion people a year continue to smoke and 30% of all cancers are linked to tobacco use. Despite new smoking cessation pharmacotherapies, quit rates remain at less than 10%. A major lack of success is due to nicotine withdrawal symptomology. Current research suggests glial immune responses in the brain and subsequent neuroinflammation may underlie the negative symptomology. While neuroinflammation and associated gliosis has been demonstrated to be a primary mediator of many neurological disorders, including in CNS trauma, ischemia, stroke, and neurodegenerative diseases, its role in nicotine dependence tobacco use disorder has not been investigated. The microglia as the resident immune cells of the brain respond to changes in the microenvironment and respond by polarization into proinflammatory and anti-inflammatory states. We postulate that attenuating microgliosis pharmacologically will reduce the anxiety-like responses during nicotine withdrawal. Using a mouse animal model of nicotine dependence, we will investigate pharmacological compounds possessing both structurally and mechanistically distinct mechanisms of action for inhibiting this inflammation. Attenuation of the microglial activation should reduce the anxiety-like behaviors occurring during nicotine withdrawal by ameliorating the neuroinflammatory response and altering the secreted effector molecules landscape. These changes will be probed behaviorally and molecularly, concentrating on microglial morphology, and effector molecule measurements (cytokine and chemokines) at both the gene and protein levels. Changes in microglial response and signaling will add clinically relevant insight into mechanisms for neuroinflammation as a target of nicotine use disorder. This innovative approach could expand the pharmacological toolbox for smoking cessation and reduce the 7 million people a year tobacco related death toll.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金